Found: 7
Select item for more details and to access through your institution.
Development of actionable targets of multi-kinase inhibitors (AToMI) screening platform to dissect kinase targets of staurosporines in glioblastoma cells.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-18118-7
- By:
- Publication type:
- Article
Optimized design and analysis of preclinical intervention studies in vivo.
- Published in:
- Scientific Reports, 2016, p. 30723, doi. 10.1038/srep30723
- By:
- Publication type:
- Article
PP2A‐based triple‐strike therapy overcomes mitochondrial apoptosis resistance in brain cancer cells.
- Published in:
- Molecular Oncology, 2023, v. 17, n. 9, p. 1803, doi. 10.1002/1878-0261.13488
- By:
- Publication type:
- Article
Stem cells are the most sensitive screening tool to identify toxicity of GATA4-targeted novel small-molecule compounds.
- Published in:
- Archives of Toxicology, 2018, v. 92, n. 9, p. 2897, doi. 10.1007/s00204-018-2257-1
- By:
- Publication type:
- Article
Label-free quantitative phosphoproteomics with novel pairwise abundance normalization reveals synergistic RAS and CIP2A signaling.
- Published in:
- Scientific Reports, 2015, p. 13099, doi. 10.1038/srep13099
- By:
- Publication type:
- Article
Affinity chromatography reveals direct binding of the GATA4–NKX2-5 interaction inhibitor (3i-1000) with GATA4.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-59418-4
- By:
- Publication type:
- Article
Switching of hypertrophic signalling towards enhanced cardiomyocyte identity and maturity by a GATA4-targeted compound.
- Published in:
- Stem Cell Research & Therapy, 2024, v. 15, n. 1, p. 1, doi. 10.1186/s13287-023-03623-x
- By:
- Publication type:
- Article